1st Quarter - Report

FABIANI & COMPANY for IPIERIAN, INC.

Period 1st Quarter 2011 Filed Jul 7, 2011 Signed by Gary Martin, CFO

Official filing
Firm
FABIANI & COMPANY
Client
IPIERIAN, INC.
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Secure funding to support drug research and development

LobbyistCovered position, as disclosed
ELIZABETH BARROWS —
MELISSA DUPREE —

Contacted: SENATE; Natl Institutes of Health (NIH); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES

Defense DEF

Secure funding to support drug research and development

LobbyistCovered position, as disclosed
ELIZABETH BARROWS —
MELISSA DUPREE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Natl Institutes of Health (NIH)

Veterans VET

Secure funding to support drug research and development

LobbyistCovered position, as disclosed
ELIZABETH BARROWS —
MELISSA DUPREE —

Contacted: SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Health Issues HCR

Secure funding to support drug research and development

LobbyistCovered position, as disclosed
ELIZABETH BARROWS —
MELISSA DUPREE —

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.